This message was sent to ##Email##
|
|
|
|
|
| |
Pharmacy Times
Despite signs that influenza activity is declining, overall activity remains elevated across most of the U.S. following this season’s peak in early February, according to the CDC’s latest FluView report.
READ MORE
Modern Medicine Network
As robotics and other systems improve, the physical aspect of pharmacy dispensing is bound to change how pharmacists do their job.
READ MORE
The Arizona Pharmacy Association Continuing Education Department is committed in offering high quality, innovative, and appropriate educational opportunities that meet or exceed professional standards for excellence in programming, safety and participant/audience amenities for pharmacists and pharmacy technicians in the state of Arizona.
For additional information or to register for a program, please click on the program title.
AzPA Pain Management Certificate Program
March 24, 2018
This program consist of 26 hours of home study and a 3.5 hour virtual webinar.
AzPA Immunization Delivery Certificate Training Program
April 14, 2018 – Glendale, AZ
APhA’s Diabetes Certificate Program
April 14, 2018 – Phoenix, AZ
AzPA Anticoagulation Certificate Program
April 27, 2018 – Tucson, AZ
APhA Pharmacy-Based Cardiovascular Disease Risk Management Certificate Program
April 27, 2018 – Tucson, AZ
Southwestern Clinical Pharmacy Seminar
April 27-29, 2018 - Tucson, AZ
AzPA Psychiatric Certificate Training Program
June 14, 2018 - Chandler, AZ
AzPA Immunization Delivery Certificate Training Program
June 14, 2018 - Chandler, AZ
APhA’s Diabetes Certificate Program 6-14-18
June 14, 2018 - Chandler, AZ
Southwestern States Residency Conference
June 15, 2018 - Chandler, AZ
AzPA Pain Management Certificate Program
July 28, 2018
This program consist of 26 hours of home study and a 3.5 hour virtual webinar.
Save the Date
Pharmacy Day at the Capitol
April 19, 2018
AzPA 2018 Annual Convention
June 14-17, 2018 - Chandler, AZ
Save the date.
Stay updated with what’s going on with AzPA. Like our Facebook page, to see current information, events, and promotions.
Arizona State Board of Pharmacy
Prescribers and pharmacists have a corresponding responsibility concerning patient care. For more information on the changes made by the 2018 First Special Session in the Arizona Opioid Epidemic Act, go online to the Final Amended Fact Sheet for SB 1001/HB2001 or the language for the Chapter Bill. The information provided herein should not be construed as a legal interpretation.
READ MORE
AzPA
Dear Community Pharmacist:
We are inviting you to participate in an online survey study of pharmacists in the United States regarding access to contraception in pharmacies. This study is being conducted by members of the American College of Clinical Pharmacy Women’s Health Practice and Research Network. The survey will take approximately 15 minutes to complete.
This survey is confidential. No personal identifiers will be collected and all results will be presented in aggregate form only. Additional details are available in the online survey at the link below.
To thank participants, there will be a drawing for an iPad Mini. You can enter the drawing upon completing the survey.
To participate, please follow this link: https://www.surveymonkey.com/r/AZpharmacists
Thank you in advance for your consideration and time. We truly appreciate your participation.
Sincerely,
Women’s Health Practice and Research Network Research Group
Medical News Today
Benadryl is a widely used medication for treating allergy symptoms, but it can cause problems when mixed with alcohol.
READ MORE
Dr. Abimbola Farinde
 In recent years, knowledge of the existence of biosimilars has grown. A biosimilar is a biologic medicine that is shown to be similar to an approved innovative biological product or drug. Unlike generic drugs, in which the active ingredients are identical, biosimilars do have key differences from the reference product. Congress and the FDA designed an expedited pathway for the approval of biosimilars. But with this process comes the need for improved patient education.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
Modern Medicine Network
For the first time in more than a decade, a new drug class has been introduced for treatment of glaucoma.
READ MORE
Pharmacy Times
Officials with the FDA have issued a statement warning consumers to be wary of unapproved products that claim to prevent, treat or cure influenza, according to the agency's press release.
This year’s flu season not only resulted in a significant number of flu infections, but also an uptick in concerns regarding the potential of individuals purchasing unapproved products.
READ MORE
|
|
|
|
50 Minthorn Blvd.Suite 800, Thornhill, Ontario L3T 7X8
|
